Systems biology of infectious diseases: A focus on fungal infections

Immunobiology

Volumn 216, Issue 11, 2011, Pages 1212-1227

  Santamaría, Rodrigo ^a   Rizzetto, Lisa ^b   Bromley, Michael ^c   Zelante, Teresa ^d   Lee, Wanseon ^e   Cavalieri, Duccio ^b   Romani, Luigina ^d   Miller, Brian ^f   Gut, Ivo ^g   Santos, Manuel ^h   Pierre, Philippe ⁱ   Bowyer, Paul ^c   Kapushesky, Misha ^e  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF PERUGIA   (Italy)

^e EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

^f Centro Nacional de Análisis Genómico ^*  (United Kingdom)

^g Centro Nacional de Análisis Genómico   (Spain)

^h UNIVERSITY OF AVEIRO   (Portugal)

ⁱ CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

Drug development; Fungal diseases; Host pathogen interaction; Infectious diseases; Systems biology

Indexed keywords

ALLYLAMINE DERIVATIVE; AMPHOTERICIN B; ECHINOCANDIN; FLUCYTOSINE; MORPHOLINE DERIVATIVE; POLYENE; PYRROLE DERIVATIVE; THIOCARBAMIC ACID DERIVATIVE;

ADAPTIVE IMMUNITY; ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; DATA ANALYSIS; DISEASE MARKER; DRUG DESIGN; DRUG SAFETY; DRUG TARGETING; EXPERIMENTAL STUDY; FUNGUS IDENTIFICATION; FUNGUS IMMUNITY; GENE TECHNOLOGY; GENETIC VARIABILITY; GENOME ANALYSIS; HIGH THROUGHPUT SEQUENCING; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; INNATE IMMUNITY; MATHEMATICAL MODEL; MOLECULAR RECOGNITION; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA SEQUENCE; SUPPORT VECTOR MACHINE; SYSTEMS BIOLOGY; TH1 CELL; TH17 CELL; TH2 CELL; UNSPECIFIED SIDE EFFECT; VALIDATION PROCESS;

EID: 80053313333     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.08.004     Document Type: Review

References (158)

1. Aderem A. Systems biology: its practice and challenges. Cell 2005, 121(4):511-513.
2. Aderem A., Smith K.D. A systems approach to dissecting immunity and inflammation. Semin. Immunol. 2004, 16(1):55-67.
3. Allison D.B., Cui X., Page G.P., Sabripour M. Microarray data analysis: from disarray to consolidation and consensus. Nat. Rev. Genet. 2006, 7(1):55-65.
4. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., Harris M.A., Hill D.P., Issel-Tarver L., Kasarskis A., Lewis S., Matese J.C., Richardson J.E., Ringwald M., Rubin G.M., Sherlock G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25(1):25-29.
5. Auffray C., Imbeaud S., Roux-Rouquilé M., Hood L. From functional genomics to systems biology: concepts and practices. Comptes Rendus Biologies 2003, 326(10-11):879-892.
6. Azor M., Cano J., Gené J., Guarro J. High genetic diversity and poor in vitro response to antifungals of clinical strains of Fusarium oxysporum. J. Antimicrob. Chemother. 2009, 63(6):1152-1155.
7. Backer M.D.D., Magee P.T., Pla J. Recent developments in molecular genetics of Candida albicans. Annu. Rev. Microbiol. 2000, 54:463-498.
8. Beltrame L., Rizzetto L., Paola R., Rocca-Serra P., Gambineri L., Battaglia C., Cavalieri D. Using pathway signatures as means of identifying similarities among microarray experiments. PLoS One 2009, 4(1):e4128.
9. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. 1995, 57(1):289-300.
10. Berry M.P.R., Graham C.M., McNab F.W., Xu Z., Bloch S.A.A., Oni T., Wilkinson K.A., Banchereau R., Skinner J., Wilkinson R.J., Quinn C., Blankenship D., Dhawan R., Cush J.J., Mejias A., Ramilo O., Kon O.M., Pascual V., Banchereau J., Chaussabel D., O/'Garra A. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010, 466(7309):973-977.
11. Bonifazi P., D'Angelo C., Zagarella S., Zelante T., Bozza S., De Luca A., Giovannini G., Moretti S., Iannitti R.G., Fallarino F., Carvalho A., Cunha C., Bistoni F., Romani L. Intranasally delivered siRNA targeting PI3K/Akt/mTOR inflammatory pathways protects from aspergillosis. Mucosal Immunol. 2010, 3(2):193-205.
12. Bonifazi P., Zelante T., D'Angelo C., De Luca A., Moretti S., Bozza S., Perruccio K., Iannitti R.G., Giovannini G., Volpi C., Fallarino F., Puccetti P., Romani L. Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. Mucosal Immunol. 2009, 2(4):362-374.
13. Bourgeois C., Majer O., Tierney L., Kuchler K. Fungal attacks on mammalian hosts: pathogen elimination requires sensing and tasting. Curr. Opin. Microbiol. 2010, 13(4):401-408.
14. Bucinski A., Socha A., Wnuk M., Baczek T., Nowaczyk A., Krysinski J., Gorynski K., Koba M. Artificial neural networks in prediction of antifungal activity of a series of pyridine derivates against Candida albicans. J. Microbiol. Meth. 2009, 76(1):25-29.
15. Buschow S.I., Lasonder E., van Deutekom H.W.M., Oud M.M., Beltrame L., Huynen M.A., de Vries I.J.M., Figdor C.G., Cavalieri D. Dominant processes during human dendritic cell maturation revealed by integration of proteome and transcriptome at the pathway level. J. Proteome Res. 2010, 9(4):1727-1737.
16. Butala M., Busby S.J.W., Lee D.J. DNA sampling: a method for probing protein binding at specific loci on bacterial chromosomes. Nucleic Acids Res. 2009, 37(5):e37.
17. Butcher E.C., Berg E.L., Kunkel E.J. Systems biology in drug discovery. Nat. Biotechnol. 2004, 22(10):1253-1259.
18. Calderone R., Fonzi W. Virulence factors of Candida albicans. Trends Microbiol. 2001, 9(7):327-335.
19. Carro M.S., Lim W.K., Alvarez M.J., Bollo R.J., Zhao X., Snyder E.Y., Sulman E.P., Anne S.L., Doetsch F., Colman H., Lasorella A., Aldape K., Califano A., Iavarone A. The transcriptional network of mesenchymal transformation of brain tumours. Nature 2010, 463(7279):318-325.
20. Casadevall A., Pirofski L. Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect. Immun. 1999, 67(8):3703-3713.
21. Casadevall A., Pirofski L.A. Host-pathogen interactions: the attributes of virulence. J. Infect. Dis. 2001, 184(3):337-344.
22. Casadevall A., Pirofski L. What is a pathogen?. Ann. Med. 2002, 34(1):2-4.
23. Cavalieri D., Castagnini C., Toti S., Maciag K., Kelder T., Gambineri L., Angioli S., Dolara P. Eu.Gene Analyzer a tool for integrating gene expression data with pathway databases. Bioinformatics (Oxford, England) 2007, 23(19):2631-2632.
24. Conti H.R., Gaffen S.L. Host responses to Candida albicans: Th17 cells and mucosal candidiasis. Microbes Infect. 2010, 12(7):518-527.
25. Cutler J. Putative virulence factors of Candida albicans. Annu. Rev. Microbiol. 1991, 45:187-218.
26. Dan J.M., Wang J.P., et al. Cooperative stimulation of dendritic cells by Cryptococcus neoformans mannoproteins and CpG oligodeoxynucleotides. PLoS One 2008, 3(4):e2046.
27. De Luca A., Zelante T., et al. IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol. 2010, 3(4):361-373.
28. Dembele D., Kastner P. Fuzzy C-means method for clustering microarray data. Bioinformatics 2003, 19(8):973-980.
29. Doniger S., Salomonis N., Dahlquist K., Vranizan K., Lawlor S., Conklin B. MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol. 2003, 4(1):R7.
30. Draghici S., Khatri P., Tarca A., Amin K., Done A., Voichita C., Georgescu C., Romero R. A systems biology approach for pathway level analysis. Genome Res. 2007, 17(10):1537-1545.
31. Drew R., Townsend M. Antifungal drug resistance: clinical relevance and impact of antifungal drug use. Curr. Fungal Infect. Rep. 2010, 4(2):129-136.
32. Ein-Dor L., Kela I., Getz G., Givol D., Domany E. Outcome signature genes in breast cancer: is there a unique set?. Bioinformatics (Oxford, England) 2005, 21(2):171-178.
33. Ein-Dor L., Zuk O., Domany E. Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(15):5923-5928.
34. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U.S.A. 1998, 95(25):14863-14868.
35. Espinel-Ingroff A. Mechanisms of resistance to antifungal agents: yeasts and filamentous fungi. Rev. Iberoam. Micol. 2008, 25:101-106.
36. Eyerich K., Foerster S., et al. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J. Invest. Dermatol. 2008, 128(11):2640-2645.
37. Fernandez-Arenas E., Cabezon V., Bermejo C., Arroyo J., Nombela C., Diez-Orejas R., Gil C. Integrated proteomics and genomics strategies bring new insight into Candida albicans response upon macrophage interaction. Mol. Cell. Proteomics 2007, 6(3):460-478.
38. Ferwerda B., Ferwerda G., Plantinga T.S., Willment J.A., van Spriel A.B., Venselaar H., Elbers C.C., Johnson M.D., Cambi A., Huysamen C., Jacobs L., Jansen T., Verheijen K., Masthoff L., Morre S.A., Vriend G., Williams D.L., Perfect J.R., Joosten L.A.B., Wijmenga C., van der Meer J.W.M., Adema G.J., Kullberg B.J., Brown G.D., Netea M.G. Human dectin-1 deficiency and mucocutaneous fungal infections. New Engl. J. Med. 2009, 361(18):1760-1767.
39. Forst C.V. Host-pathogen systems biology. Drug Discov. Today 2006, 11(5-6):220-227.
40. Fu L., Medico E. FLAME, a novel fuzzy clustering method for the analysis of DNA microarray data. BMC Bioinformatics 2007, 8(1):3.
41. Gardy J.L., Lynn D.J., Brinkman F.S.L., Hancock R.E.W. Enabling a systems biology approach to immunology: focus on innate immunity. Trends Immunol. 2009, 30(6):249-262.
42. Ge D., Fellay J., Thompson A.J., Simon J.S., Shianna K.V., Urban T.J., Heinzen E.L., Qiu P., Bertelsen A.H., Muir A.J., Sulkowski M., McHutchison J.G., Goldstein D.B. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009, 461(7262):399-401.
43. Giaever G., Shoemaker D.D., Jones T.W., Liang H., Winzeier E.A., Astromoff A., Davis R.W. Genomic profiling of drug sensitivities via induced haploinsufficiency. Nat. Genet. 1999, 21:278-283.
44. Gilchrist M., Thorsson V., Li B., Rust A.G., Korb M., Kennedy K., Hai T., Bolouri H., Aderem A. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 2006, 441(7090):173-178.
45. Glocker E., Hennigs A., Nabavi M., Schaffer A.A., Woellner C., Salzer U., Pfeifer D., Veelken H., Warnatz K., Tahami F., Jamal S., Manguiat A., Rezaei N., Amirzargar A.A., Plebani A., Hannesschlager N., Gross O., Ruland J., Grimbacher B. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. New Engl. J. Med. 2009, 361(18):1727-1735.
46. Goeman J., van de Geer S., de Kort F., van Houwelingen H. A global test for groups of genes: testing association with a clinical outcome. Bioinformatics (Oxford, England) 2004, 20(1):93-99.
47. Gomes A.C., Miranda I., Silva R.M., Moura G.R., Thomas B., Akoulitchev A., Santos M.A. A genetic code alteration generates a proteome of high diversity in the human pathogen Candida albicans. Genome Biol. 2007, 8:R206.
48. Gong Y., Kakihara Y., Krogan N., Greenblatt J., Emili A., Zhang Z., Houry W.A. An atlas of chaperone-protein interactions in Saccharomyces cerevisiae: implications to protein folding pathways in the cell. Mol. Syst. Biol. 2009, 5.
49. Goodridge H.S., Wolf A.J., et al. Beta-glucan recognition by the innate immune system. Immunol. Rev. 2009, 230(1):38-50.
50. Grosu P., Townsend J., Hartl D., Cavalieri D. Pathway Processor: a tool for integrating whole-genome expression results into metabolic networks. Genome Res. 2002, 12(7):1121-1126.
51. Guimaraes A.J., Frases S., et al. Monoclonal antibodies to heat shock protein 60 alter the pathogenesis of Histoplasma capsulatum. Infect. Immun. 2009, 77(4):1357-1367.
52. Hawn T.R., Wu H., Grossman J.M., Hahn B.H., Tsao B.P., Aderem A. A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(30):10593-10597.
53. Hermjakob H., Montecchi-Palazzi L., Bader G., Wojcik J., Salwinski L., Ceol A., Moore S., Orchard S., Sarkans U., von Mering C., Roechert B., Poux S., Jung E., Mersch H., Kersey P., Lappe M., Li Y., Zeng R., Rana D., Nikolski M., Husi H., Brun C., Shanker K., Grant S.G.N., Sander C., Bork P., Zhu W., Pandey A., Brazma A., Jacq B., Vidal M., Sherman D., Legrain P., Cesareni G., Xenarios I., Eisenberg D., Steipe B., Hogue C., Apweiler R. The HUPO PSI's molecular interaction format - a community standard for the representation of protein interaction data. Nat. Biotechnol. 2004, 22(2):177-183.
54. Hill A.B. The environment and disease: association or causation?. Proc. R. Soc. Med. 1965, 58:295-300.
55. Hogan L., Klein B., Levitz S. Virulence factors of medically important fungi. Clin. Microbiol. Rev. 1996, 9(4):469-488.
56. Hope W.W., Walsh T.J., et al. Laboratory diagnosis of invasive aspergillosis. Lancet Infect. Dis. 2005, 5(10):609-622.
57. Hu W., Sillaots S., Lemieux S., Davison J., Kauffman S., Breton A., Linteau A., Xin C., Bowman J., Becker J., Jiang B., Roemer T. Essential gene identification and drug target prioritization in Aspergillus fumigatus. PLoS Pathog. 2007, 3(3):e24.
58. Hu J., Nistal-Villén E., Voho A., Ganee A., Kumar M., Ding Y., García-Sastre A., Wetmur J.G. A common polymorphism in the caspase recruitment domain of RIG-I modifies the innate immune response of human dendritic cells. J. Immunol. (Baltimore, Md.: 1950) 2010, 185(1):424-432.
59. Huang Q., Liu D., Majewski P., Schulte L.C., Korn J.M., Young R.A., Lander E.S., Hacohen N. The plasticity of dendritic cell responses to pathogens and their components. Science 2001, 294(5543):870-875.
60. Hucka M., Finney A., Bornstein B., Keating S., Shapiro B., Matthews J., Kovitz B., Schilstra M., Funahashi A., Doyle J., Kitano H. Evolving a lingua franca and associated software infrastructure for computational systems biology: the Systems Biology Markup Language (SBML) project. Syst. Biol. 2004, 1(1):41.
61. Hwang D., Lee I.Y., Yoo H., Gehlenborg N., Cho J., Petritis B., Baxter D., Pitstick R., Young R., Spicer D., Price N.D., Hohmann J.G., DeArmond S.J., Carlson G.A., Hood L.E. A systems approach to prion disease. Mol. Syst. Biol. 2009, 5.
62. Ideker T., Galitski T., Hood L. A new approach to decoding life: systems biology. Annu. Rev. Genomics Hum. Genet. 2001, 2(1):343-372.
63. Irizarry R.A., Wang C., Zhou Y., Speed T.P. Gene set enrichment analysis made simple. Stat. Methods Med. Res. 2009, 18(6):565-575.
64. Jenner R.G., Young R.A. Insights into host responses against pathogens from transcriptional profiling. Nat. Rev. Microbiol. 2005, 3(4):281-294.
65. Jiang B. PAP inhibitor with in vivo efficacy identified by Candida albicans genetic profiling of natural products. Chem. Biol. 2008, 15(4):363-374.
66. Kanafani Z.A., Perfect J.R. Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. Clin. Infect. Dis. 2008, 46(1):120-128.
67. Kanehisa M., Araki M., Goto S., Hattori M., Hirakawa M., Itoh M., Katayama T., Kawashima S., Okuda S., Tokimatsu T., Yamanishi Y. KEGG for linking genomes to life and the environment. Nucl. Acids Res. 2008, 36(Suppl. 1):D480-D484.
68. Kansal A.R. Modeling approaches to type 2 diabetes. Diabetes Technol. Ther. 2004, 6(1):39-47.
69. Kapushesky M., Emam I., Holloway E., Kurnosov P., Zorin A., Malone J., Rustici G., Williams E., Parkinson H., Brazma A. Gene Expression Atlas at the European Bioinformatics Institute. Nucl. Acids Res. 2009, 38(Database):D690-D698.
70. Keseler I.M., Collado-Vides J., Gama-Castro S., Ingraham J., Paley S., Paulsen I.T., Peralta-Gil M., Karp P.D. EcoCyc: a comprehensive database resource for Escherichia coli. Nucl. Acids Res. 2005, 33(Suppl. 1):D334-D337.
71. Khatri P., Draghici S., Ostermeier G., Krawetz S. Profiling gene expression using onto-express. Genomics 2002, 79(2):266-270.
72. Khot P.D., Suci P.A., Miller R.L., Nelson R.D., Tyler B.J. A small subpopulation of blastospores in Candida albicans biofilms exhibit resistance to Amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes. Antimicrob. Agents Chemother. 2006, 50(11):3708-3716.
73. Kitano H. A robustness-based approach to systems-oriented drug design. Nat. Rev. Drug Discov. 2007, 5(3):202-210.
74. Kitano H. Computational systems biology. Nature 2002, 420(6912):206-210.
75. Kitano H. Systems biology: a brief overview. Science 2002, 295(5560):1662-1664.
76. Kitano H. Perspectives on systems biology. New Generation Comput. 2000, 18(3):199-216.
77. Latge J.P. Tasting the fungal cell wall. Cell. Microbiol. 2010, 12(7):863-872.
78. Leibundgut-Landmann S., Gross O., et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 2007, 8(6):630-638.
79. Levitz S.M. Innate recognition of fungal cell walls. PLoS Pathog. 2010, 6(4):e1000758.
80. Lewis S.A., Corden J.M., Forster G.E., Newlands M. Combined effects of aerobiological pollutants, chemical pollutants and meteorological conditions on asthma admissions and A & E attendances in Derbyshire UK, 1993-1996. Clin. Exp. Allergy 2000, 30(12):1724-1732.
81. Lewis A., Paterson T., Leong C., Defranoux N., Holgate S., Stokes C. The roles of cells and mediators in a computer model of chronic asthma. Int. Arch. Allergy Immunol. 2001, 124(1-3):282-286.
82. Lewis D.F.V., Modi S., Dickins M. Structure-activity relationship for human cytochrome P450 substrates and inhibitors. Drug Metab. Rev. 2002, 34(1-2):69-82.
83. Lorenz M.C., Bender J.A., Fink G.R. Transcriptional response of Candida albicans upon internalization by macrophages. Eukaryotic Cell 2004, 3(5):1076-1087.
84. Lukk M., Kapushesky M., Nikkila J., Parkinson H., Goncalves A., Huber W., Ukkonen E., Brazma A. A global map of human gene expression. Nat. Biotechnol. 2010, 28(4):322-324.
85. Lum P.Y., Armour C.D., Stepaniants S.B., Cavet G., Wolf M.K., Butler J.S., Hinshaw J.C., Garnier P., Prestwich G.D., Leonardson A., Garrett-Engele P., Rush C.M., Bard M., Schimmack G., Phillips J.W., Roberts C.J., Shoemaker D.D. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 2004, 116(1):121-137.
86. Madeira S.C., Oliveira A.L. Biclustering algorithms for biological data analysis: a survey. IEEE/ACM Trans. Comput. Biol. Bioinform. 2004, 1(1):24-45.
87. Manoli T., Gretz N., Gröne H., Kenzelmann M., Eils R., Brors B. Group testing for pathway analysis improves comparability of different microarray datasets. Bioinformatics 2006, 22(20):2500-2506.
88. Margolin A.A., Wang K., Lim W.K., Kustagi M., Nemenman I., Califano A. Reverse engineering cellular networks. Nat. Protoc. 2006, 1(2):662-671.
89. Massey S.E., Moura G., Beltrão P., Almeida R., Garey J.R., Tuite M.F., Santos M.A.S. Comparative evolutionary genomics unveils the molecular mechanism of reassignment of the CTG codon in Candida spp. Genome Res. 2003, 13:544.
90. Matthews L., Gopinath G., Gillespie M., Caudy M., Croft D., de Bono B., Garapati P., Hemish J., Hermjakob H., Jassal B., Kanapin A., Lewis S., Mahajan S., May B., Schmidt E., Vastrik I., Wu G., Birney E., Stein L., D'Eustachio P. Reactome knowledgebase of human biological pathways and processes. Nucl. Acids Res. 2009, 37(Suppl. 13):D619-D622.
91. Matys V., Fricke E., Geffers R., Gossling E., Haubrock M., Hehl R., Hornischer K., Karas D., Kel A.E., Kel-Margoulis O.V., Kloos D., Land S., Lewicki-Potapov B., Michael H., Munch R., Reuter I., Rotert S., Saxel H., Scheer M., Thiele S., Wingender E. TRANSFAC(R), transcriptional regulation, from patterns to profiles. Nucl. Acids Res. 2003, 31(1):374-378.
92. McClelland E.E., Nicola A.M., et al. Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism. J. Clin. Invest. 2010, 120(4):1355-1361.
93. McDermott J.E., Costa M., Janszen D., Singhal M., Tilton S.C. Separating the drivers from the driven: Integrative network and pathway approaches aid identification of disease biomarkers from high-throughput data. Dis. Markers 2010, 28(4):253-266.
94. McGrath M.S., Kodelja V. Balanced macrophage activation hypothesis: a biological model for development of drugs targeted at macrophage functional states. Pathobiology 1999, 67(5-6):277-281.
95. Means T.K., Mylonakis E., et al. Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J. Exp. Med. 2009, 206(3):637-653.
96. Mezger M., Einsele H., Loeffler J. Genetic susceptibility to infections with Aspergillus fumigatus. Crit. Rev. Microbiol. 2010, 36(2):168-177.
97. Mezger M., Steffens M., Beyer M., Manger C., Eberle J., Toliat M., Wienker T.F., Ljungman P., Hebart H., Dornbusch H.J., Einsele H., Loeffler J. Polymorphisms in the chemokine (C-X-C motif) ligand 10 are associated with invasive aspergillosis after allogeneic stem-cell transplantation and influence CXCL10 expression in monocyte-derived dendritic cells. Blood 2008, 111(2):534-536.
98. Milner J.D., Brenchley J.M., et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008, 452(7188):773-776.
99. Miranda I., Rocha R., Santos M.C., Mateus D.D., Moura G.R., Carreto L., Santos M.A. A genetic code alteration is a phenotype diversity generator in the human pathogen Candida albicans. PLoS One 2007, 2:e996.
100. Mitchell A. Dimorphism and virulence in Candida albicans. Curr. Opin. Microbiol. 1998, 1(6):687-692.
101. Mockler T.C., Eckler J.R. Applications of DNA tiling arrays for whole-genome analysis. Genomics 2005, 85(1):1-15.
102. Morio F., Loge C., Besse B., Hennequin C., Pape P.L. Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature. Diagn. Microbiol. Infect. Dis. 2010, 66(4):373-384.
103. Mueller L.A., Zhang P., Rhee S.Y. AraCyc: a biochemical pathway database for Arabidopsis. Plant Physiol. 2003, 132(2):453-460.
104. Murphy K.M., Travers P., Walport M. Janeway's Immunobiology 2008, Seventh edition.
105. Nau G.J., Richmond J.F.L., Schlesinger A., Jennings E.G., Lander E.S., Young R.A. Human macrophage activation programs induced by bacterial pathogens. Proc. Natl. Acad. Sci. U.S.A. 2002, 99(3):1503-1508.
106. Netea M.G., Brown G.D., Kullberg B.J., Gow N.A.R. An integrated model of the recognition of Candida albicans by the innate immune system. Nat. Rev. Microbiol. 2008, 6(1):67-78.
107. O'Malley M.A., Dupré J. Fundamental issues in systems biology. BioEssays 2005, 27(12):1270-1276.
108. Odds F., Gow N., Brown A. Fungal virulence studies come of age. Genome Biol. 2001, 2(3). (reviews 1009).
109. Pappas P.G. Opportunistic fungi: a view to the future. Am. J. Med. Sci. 2010, 340(3):253-257.
110. Payne D.J., Gwynn M.N., Holmes D.J., Pompliano D.L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. 2007, 6:29-40.
111. Peman J., Canton E., Espinel-Ingroff A. Antifungal drug resistance mechanisms. Expert Rev. Anti-Infect. Ther. 2009, 7(4):453-460.
112. Peng X., Chan E.Y., Li Y., Diamond D.L., Korth M.J., Katze M.G. Virus-host interactions: from systems biology to translational research. Curr. Opin. Microbiol. 2009, 12(4):432-438.
113. Pitarch A., Jiménez A., Nombela C., Gil C. Decoding serological response to Candida cell wall immunome into novel diagnostic, prognostic and therapeutic candidates for systemic candidiasis by proteomic and bioinformatic analyses. Mol. Cell. Proteomics 2006, 5:79-96.
114. Plantinga T.S., van der Velden W.J.F.M., Ferwerda B., van Spriel A.B., Adema G., Feuth T., Donnelly J.P., Brown G.D., Kullberg B., Blijlevens N.M.A., Netea M.G. Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 2009, 49(5):724-732.
115. Querec T.D., Akondy R.S., Lee E.K., Cao W., Nakaya H.I., Teuwen D., Pirani A., Gernert K., Deng J., Marzolf B., Kennedy K., Wu H., Bennouna S., Oluoch H., Miller J., Vencio R.Z., Mulligan M., Aderem A., Ahmed R., Pulendran B. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 2009, 10(1):116-125.
116. Raman K., Bhat A.G., Chandra N. A systems perspective of host-pathogen interactions: predicting disease outcome in tuberculosis. Mol. Biosyst. 2010, 6:516-530.
117. Raza S., Robertson K., Lacaze P., Page D., Enright A., Ghazal P., Freeman T. A logic-based diagram of signalling pathways central to macrophage activation. BMC Syst. Biol. 2008, 2:36.
118. Reiss D.J., Baliga N.S., Bonneau R. Integrated biclustering of heterogeneous genome-wide datasets for the inference of global regulatory networks. BMC Bioinformatics 2006, 7(280).
119. Rizzetto L., Cavalieri D. A systems biology approach to the mutual interaction between yeast and the immune system. Immunobiology 2010, 215(9-10):762-769.
120. Rizzetto L., Kuka M., Filippo C.D., Cambi A., Netea M.G., Beltrame L., Napolitani G., Torcia M.G., D'Oro U., Cavalieri D. Differential IL-17 production and mannan recognition contribute to fungal pathogenicity and commensalism. J. Immunol. (Baltimore, Md.: 1950) 2010, 184(8):4258-4268.
121. Rodland E.K., Mattingsdal M., Olstad O.K., Ovstebo R., Kierulf P., Muller F., Froland S.S. Expression of genes in normal human monocytes in response to Aspergillus fumigatus. Med. Mycol. 2008, 46(4):327-336.
122. Roemer T., Jiang B., Davison J., Ketela T., Veillette K., Breton A., Tandia F., Linteau A., Sillaots S., Marta C., Martel N., Veronneau S., Lemieux S., Kaufmann S., Becker J., Storms R., Boone C., Bussey H. Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery. Mol. microbiol. 2003, 50(1):167-181.
123. Romani L. Immunity to fungal infections. Nat. Rev. Immunol. 2004, 4(1):11-24.
124. Romani L., Bistoni F., et al. Fungi, dendritic cells and receptors: a host perspective of fungal virulence. Trends Microbiol. 2002, 10(11):508-514.
125. Romani L., Kaufmann S.H. Immunity to fungi: editorial overview. Res. Immunol. 1998, 149(4-5):277-281.
126. Romani L., Puccetti P. Protective tolerance to fungi: the role of IL-10 and tryptophan catabolism. Trends Microbiol. 2006, 14(4):183-189.
127. Romani L., Zelante T., De Luca A., Fallarino F., Puccetti P. IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi. J. Immunol. 2008, 180:5157-5162.
128. Ruepp A., Zollner A., Maier D., Albermann K., Hani J., Mokrejs M., Tetko I., Guldener U., Mannhaupt G., Munsterkotter M., Mewes H.W. The FunCat, a functional annotation scheme for systematic classification of proteins from whole genomes. Nucl. Acids Res. 2004, 32(18):5539-5545.
129. Sainz J., Salas-Alvarado I., Lopez-Fernández E., Olmedo C., Comino A., García F., Blanco A., Gomez-Lopera S., Oyonarte S., Bueno P., Jurado M. TNFR1 mRNA expression level and TNFR1 gene polymorphisms are predictive markers for susceptibility to develop invasive pulmonary aspergillosis. Int. J. Immunopathol. Pharmacol. 2010, 23(2):423-436.
130. Sanglard D., Coste A., Ferrari S. Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation. FEMS Yeast Res. 2009, 9(7):1029-1050.
131. Sanglard D., Odds F.C. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2002, 2(2):73-85.
132. Santamaria R., Theron R., Quintales L. A visual analytics approach for understanding biclustering results from microarray data. BMC Bioinformatics 2008, 9(1):247.
133. Smith A.M., Heisler L.E., Mellor J., Kaper F., Thompson M.J., Chee M., Roth F.P., Giaever G., Nislow C. Quantitative phenotyping via deep barcode sequencing. Genome Res. 2009, 19:1836-1842.
134. Smyth G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 2004, 3. (Article 3).
135. Soll D.R. Candida commensalism and virulence: the evolution of phenotypic plasticity. Acta Tropica 2002, 81(2):101-110.
136. Spinnler K., Mezger M., Steffens M., Sennefelder H., Kurzai O., Einsele H., Loeffler J. Role of glycogen synthase kinase 3 (GSK-3) in innate immune response of human immature dendritic cells to Aspergillus fumigatus. Med. Mycol. 2010, 48(4):589-597.
137. Stromback L., Lambrix P. Representations of molecular pathways: an evaluation of SBML, PSI MI and BioPAX. Bioinformatics 2005, 21(24):4401-4407.
138. Subramaniam K.S., Datta K., et al. The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans. J. Immunol. 2010, 184(10):5755-5767.
139. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(43):15545-15550.
140. Tavanti A., Campa D., Bertozzi A., Pardini G., Naglik J.R., Barale R., Senesi S. Candida albicans isolates with different genomic backgrounds display a differential response to macrophage infection. Microbes Infect. 2006, 8(3):791-800.
141. Thomas D.L., Thio C.L., Martin M.P., Qi Y., Ge D., O'hUigin C., Kidd J., Kidd K., Khakoo S.I., Alexander G., Goedert J.J., Kirk G.D., Donfield S.M., Rosen H.R., Tobler L.H., Busch M.P., McHutchison J.G., Goldstein D.B., Carrington M. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009, 461(7265):798-801.
142. Tournu H., Serneels J., Dijck P.V. Fungal pathogens research: novel and improved molecular approaches for the discovery of antifungal drug targets. Curr. Drug Targets 2005, 6(8):909-922.
143. van de Veerdonk F., Marijnissen R., Kullberg B., Koenen H., Cheng S., Joosten I., van den Berg W., Williams D., van der Meer J., Joosten L., Netea M. The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 2009, 5(4):329-340.
144. van der Velden W.J.F.M., Plantinga T.S., Feuth T., Donnelly J.P., Netea M.G., Blijlevens N.M.A. The incidence of acute graft-versus-host disease increases with Candida colonization depending the dectin-1 gene status. Clin. Immunol. (Orlando, Fla.) 2010, 136(2):302-306.
145. Vinh D.C., Sugui J.A., Hsu A.P., Freeman A.F., Holland S.M. Invasive fungal disease in autosomal-dominant hyper-IgE syndrome. J. Allergy Clin. Immunol. 2010, 125(6):1389-1390.
146. Wang K., Lee I., Carlson G., Hood L., Galas D. Systems biology and the discovery of diagnostic biomarkers. Dis. Markers 2010, 28(4):199-207.
147. Weston A.D., Hood L. Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J. Proteome Res. 2004, 3(2):179-196.
148. Wheelock C.E., Wheelock A.M., Kawashima S., Diez D., Kanehisa M., van Erk M., Kleemann R., Haeggstrom J.Z., Goto S. Systems biology approaches and pathway tools for investigating cardiovascular disease. Mol. Biosyst. 2009, 5(6):588-602.
149. White P.L., Barton R., Guiver M., Linton C.J., Wilson S., Smith M., Gomez B.L., Carr M.J., Kimmitt P.T., Seaton S., Rajakumar K., Holyoake T., Kibbler C.C., Johnson E., Hobson R.P., Jones B., Barnes R.A. A consensus on fungal polymerase chain reaction diagnosis?. J. Mol. Diagn. 2006, 8(3):376-384.
150. Wolkenhauer O. Systems biology: the reincarnation of systems theory applied in biology?. Brief. Bioinform. 2001, 2(3):258-270.
151. Woods J.P. Histoplasma capsulatum molecular genetics, pathogenesis, and responsiveness to its environment. Fungal Genet. Biol. 2002, 35(2):81-97.
152. Xu D., Jiang B., Ketela T., Lemieux S., Veillette K., Martel N., Davison J., Sillaots S., Trosok S., Bachewich C., Bussey H., Youngman P., Roemer T. Genome-wide fitness test and mechanism-of-action studies of inhibitory compounds in Candida albicans. PLoS Pathog. 2007, 3(6):e92.
153. Xu L., Tan A., Winslow R., Geman D. Merging microarray data from separate breast cancer studies provides a robust prognostic test. BMC Bioinformatics 2008, 9:125.
154. Zak D.E., Aderem A. Systems biology of innate immunity. Immunol. Rev. 2009, 227(1):264-282.
155. Zaslavsky E., Hershberg U., Seto J., Pham A.M., Marquez S., Duke J.L., Wetmur J.G., tenOever B.R., Sealfon S.C., Kleinstein S.H. Antiviral response dictated by choreographed cascade of transcription factors. J. Immunol. 2010, 184(6):2908-2917.
156. Zelante T., De Luca A., Romani L. Th17 cells in fungal infections. Th17 Cells in Health and Disease 2010, Springer Science Publisher, New York.
157. Zenewicz L.A., Flavell R.A. IL-22 and inflammation: leukin' through a glass onion. Eur. J. Immunol. 2008, 38(12):3265-3268.
158. Zhang L., McHale C.M., Rothman N., Li G., Ji Z., Vermeulen R., Hubbard A.E., Ren X., Shen M., Rappaport S.M., North M., Skibola C.F., Yin S., Vulpe C., Chanock S.J., Smith M.T., Lan Q. Systems biology of human benzene exposure. Chemico-Biol. Interact. 2009, 184(1-2):86-93.